More News on Dr. Borody’s Ivermectin proposal

More News on Dr. Borody's Ivermectin proposal

News Corp media is the latest major media to report on the proposal of Professor Thomas Borody. This gastroenterologist received credit for developing the world’s first peptic ulcers, saving lives in the process. What’s his proposal? Make Ivermectin available for at least those economically disadvantaged individuals--without health care access (vulnerable people)--infected with COVID-19 as the drug in real-world usage has evidenced safety and efficacy in an endeavor to reduce the severity and duration of the novel coronavirus. Professor Borody stepped up to publicly declare this need despite a great majority of health authorities that don’t think much on this topic. A few clinical trials have been completed (Bangladesh and Iraq), but because they have been on the smaller scale and TrialSite suspects (and this is just a speculation), because they originate out of low-and middle-income countries (LMICs) health regulators and research elites in richer countries aren’t paying attention. A real-world, observational off label initiative was deemed successful in Broward County U.S., but no medical journals are willing to consider a review of the findings. Borody broadcast his concerns du...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee